The results showed that LOX inhibition supressed the expression of vimentin, slug, snail and N-cadherin, and increased the expression of epithelial phenotypic markers such as E-cadherin, ZO-1, and β-cantenin (Figure 6E and Supplementary Figures S5A–G), suggesting LOX inhibition could inhibit EMT in NSCLC cells. Here, LOX is linked to non-small cell lung carcinoma.